Literature DB >> 15770395

Possible involvement of the interleukin-15 and interleukin-15 receptor system in a heightened state of lamina propria B cell activation and differentiation in patients with inflammatory bowel disease.

Tsuyoshi Nishiwaki1, Kenji Ina, Hidemi Goto, Osamu Watanabe, Tomoyuki Tsuzuki, Ryuichi Furuta, Takafumi Ando, Kenji Hibi, Kazuo Kusugami.   

Abstract

BACKGROUND: We investigated the possible roles of the interleukin (IL)-15 and IL-15 receptor (IL-15R) system in a heightened state of B-cell activation and differentiation in intestinal mucosa with inflammatory bowel disease (IBD).
METHODS: The expression of IL-15 and IL-15Ralpha mRNA and protein in inflamed colonic mucosal tissues with IBD, and in control tissues was examined by reverse transcriptase-polymerase chain reaction and immunohistological methods. The effects of recombinant (r)IL-15 on the expression of IL-15Ralpha on lamina propria B cells and the production of immunoglobulin G (IgG) were analyzed in vitro, using lamina propria mononuclear cells (LPMCs) isolated from control tissues.
RESULTS: The intensity of IL-15 and IL-15Ralpha mRNA was greater in the mucosal tissues of patients with IBD, especially in those of patients with ulcerative colitis (UC), than in control tissues. Compared to control tissues, mononuclear cells positive for IL-15Ralpha protein were observed in greater proportions in tissue sections from patients with IBD, especially in those from patients with UC, where IL-15Ralpha protein was localized to CD20-positive B cells to a significant degree. There were increases in the proportions of IL-15Ralpha-positive B cells and IgG-producing cells in rIL-15- or rCD40L-stimulated cultures of LPMCs, with stimulatory effects being greater in the presence of their combination.
CONCLUSIONS: These data suggest that the IL-15 and IL-15R system may play important roles in the activation and differentiation of lamina propria B cells in patients with IBD, especially in those with UC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770395     DOI: 10.1007/s00535-004-1510-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  13 in total

1.  Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.

Authors:  G Docena; L Rovedatti; L Kruidenier; A Fanning; N A B Leakey; C H Knowles; K Lee; F Shanahan; K Nally; P G McLean; A Di Sabatino; T T MacDonald
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

2.  Heterogeneity of asthma and the risk of celiac disease in children.

Authors:  Bhavisha Patel; Chung-Il Wi; M Earth Hasassri; Rohit Divekar; Imad Absah; Eyad Almallouhi; Euijung Ryu; Katherine King; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

3.  A case of pyoderma gangrenosum with ulcerative colitis treated with mesalazine.

Authors:  Jae In Lee; Hyun Jeong Park; Jun Young Lee; Baik Kee Cho
Journal:  Ann Dermatol       Date:  2010-11-05       Impact factor: 1.444

4.  Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis.

Authors:  Alain P Vicari; Alain M Schoepfer; Bertrand Meresse; Laurence Goffin; Olivier Léger; Soheila Josserand; Nicolas Guégan; Shida Yousefi; Alex Straumann; Nadine Cerf-Bensussan; Hans-Uwe Simon; Yolande Chvatchko
Journal:  MAbs       Date:  2017-06-05       Impact factor: 5.857

Review 5.  Pediatric inflammatory bowel disease.

Authors:  Karen-A Diefenbach; Christopher-K Breuer
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

6.  Interleukin-15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab.

Authors:  Clémentine Perrier; Ingrid Arijs; Dominiek Staelens; Christine Breynaert; Isabelle Cleynen; Kris Covens; Marc Ferrante; Gert Van Assche; Séverine Vermeire; Gert de Hertogh; Frans Schuit; Paul Rutgeerts; Jan L Ceuppens
Journal:  Immunology       Date:  2013-01       Impact factor: 7.397

Review 7.  IL-15: a central regulator of celiac disease immunopathology.

Authors:  Valérie Abadie; Bana Jabri
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

8.  Celiac disease in pediatric patients according to HLA genetic risk classes: a retrospective observational study.

Authors:  Carlo Tolone; Marisa Piccirillo; Pasquale Dolce; Salvatore Alfiero; Mattia Arenella; Marina Sarnataro; Patrizia Iardino; Alessia Pucciarelli; Caterina Strisciuglio
Journal:  Ital J Pediatr       Date:  2021-05-05       Impact factor: 2.638

9.  Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease.

Authors:  Serena Vitale; Caterina Strisciuglio; Laura Pisapia; Erasmo Miele; Pasquale Barba; Alessandra Vitale; Sabrina Cenni; Virginia Bassi; Mariantonia Maglio; Giovanna Del Pozzo; Riccardo Troncone; Annamaria Staiano; Carmen Gianfrani
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 10.  Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment.

Authors:  Moses M Kasembeli; Uddalak Bharadwaj; Prema Robinson; David J Tweardy
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.